Stocks · Financials · Blank Checks

Drugs Made In America Acquisition II Corp.

DMII Clue Score59
United States Fiscal year ends December CIK 0002040475
$10.19 +0.00% Close, 9 Oct 2026
Price $10.19 +2.00% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 3 Dec 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2025Operating income−0.5Net income4.2
FY2025
Operating income −0.5
Net income 4.2
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2025Operating cash flow−1.0
FY2025
Operating cash flow −1.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2025Cash0.0Shareholders’ equity−17.8
FY2025
Cash 0.0
Shareholders’ equity −17.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2025 31 Dec 2025
Assets
0.0
505.0
Growth
Liabilities
17.8
Equity
−17.8
−17.8
Growth
Per share and net cash
13.7
calc −1.30

Lines marked calc are worked out here from filed figures; point at one for how.